Lv52
1110 积分 2024-11-15 加入
Recent advances in, and challenges of, anti-angiogenesis agents for tumor chemotherapy based on vascular normalization
7天前
已完结
The added value of hysterectomy in the management of gestational trophoblastic neoplasia
10天前
已完结
The impact of pulmonary metastases on therapeutic response and prognosis in malignant gestational trophoblastic neoplasia patients: a retrospective cohort study
10天前
已完结
Reproductive outcomes following chemotherapy for gestational trophoblastic neoplasia: experience from a tertiary care center
10天前
已完结
Evolution of Treatment Strategies for Gestational Trophoblastic Neoplasia: Chemotherapy, Immunotherapy, and Molecular Targeted Therapy
11天前
已完结
The impact of pulmonary metastases on therapeutic response and prognosis in malignant gestational trophoblastic neoplasia patients: a retrospective cohort study
11天前
已关闭
Spatiotemporal Immune Determinants of Response to Immune Rechallenge in Advanced Cervical Cancer
13天前
已完结
EFFICACY OF DISITAMAB VEDOTIN, AK104, AND BEVACIZUMAB IN HER2-POSITIVE RECURRENT OVARIAN CLEAR CELL CANCER: PHASE 2 DAB-OCCC TRIAL
14天前
已关闭
Trastuzumab pamirtecan (DB-1303/BNT323) in patients with previously treated HER2-expressing advanced/metastatic endometrial cancer: First global clinical phase 2 data
17天前
已完结
Validated stability indicating assay method of olaparib: LC‐ESI‐Q‐TOF‐MS/MS and NMR studies for characterization of its new hydrolytic and oxidative forced degradation products
19天前
已关闭
皖公网安备34019202002308
